David S. Lawrence

• Comment: Need inline citations for all possibly contentious claims about a living person. The career section for example, has none. Further, a lot of this draft is discussing the subject's work and just linking to their work. We really aren't interested in the story of the subject, from the subject's perspective. Keep in mind we are a tertiary source that is concerned with what secondary sources says is notable about the subject. All of that fluff, which is also borderline WP:OR, need to be removed or supported with secondary sources discussing its importance. Sulfurboy (talk) 05:15, 19 October 2026 (UTC)

• Comment: If I remember correctly a named chair should be enough to pass the WP:NOTABILITY aspect for creating an article but right now there are still far too many unsourced facts in the article such as date and location of birth, the entire Early Life, Education, and Personal affiliations sections (especially this last one, you could cut the others and nothing would really change).
  The research section is also quite long but made up of what appears to be disconnected sub-sections and could be shortened or organized differently.
  I would recommend a professional photo as well but thats just me. Moritoriko (talk) 06:48, 16 October 2026 (UTC)

• Comment: Needs to be rewritten from scratch without the use of LLMs. Helpful Raccoon (talk) 00:15, 9 June 2026 (UTC)

---

This user has made a public declaration indicating that they have a conflict of interest with regard to the following Wikipedia article(s):

• David Scott Lawrence

Please note that this is autobiographical submission and therefore I am declaring a conflict of interest

David S. Lawrence
David S. Lawrence 2.jpg David S. Lawrence 2.jpg
Born
🎓 Alma mater	East Los Angeles College (AA) University of California at Irvine (BS - Biological Science) University of California at Los Angeles (PhD - Chemistry)
💼 Occupation

David S. Lawrence is the Fred Eshelman Distinguished Professor at the University of North Carolina at Chapel Hill. He is known for his work in chemical biology, developing strategies for the design of self-assembling molecular systems, methods for detecting protein kinase activity, and the construction of light-responsive proteins and drug delivery systems.

Career

Lawrence began his academic career as a faculty member in the Department of Chemistry at the State University of New York at Buffalo in 1985. He subsequently joined the Department of Biochemistry at the Albert Einstein College of Medicine in 1996, and then moved to the University of North Carolina at Chapel Hill in 2007 as the Fred Eshelman Distinguished Professor. He holds affiliated appointments across multiple schools at UNC and chaired the Division of Chemical Biology and Medicinal Chemistry in the UNC Eshelman School of Pharmacy from 2011 to 2025.

Research

Lawrence's research in chemical biology explores the design of synthetic systems that emulate or control biological processes. His work intersects the areas of supramolecular chemistry, cellular signaling, and targeted drug delivery.

State University of New York at Buffalo

Lawrence's independent research program initially focused on the design of molecules chemically pre-programmed to interact with and bind to other molecules, in vitro and in cellulo. In the area of supramolecular chemistry, his team created compounds that self-interact and assemble into multicomponent entities that mimic the oxygen carrying protein hemoglobin and the cytochrome P-450 family of proteins. These studies helped lay the groundwork for some of the guiding principles for controlled molecular assembly, which is now commonly used for creating functional chemical systems. In the area of intracellular signal transduction, he and his colleagues developed molecules programmed to target key enzymes in the biochemical signaling pathways of living cells.

The Albert Einstein College of Medicine

Several members of the large family (>500) of protein kinases have been implicated in a variety of human diseases. The active sites of these enzymes are highly conserved and, in the 1990s it was thought, that selectively inhibiting specific protein kinases could be challenging. Lawrence and his colleagues demonstrated that peptide-(small molecule) hybrids could selectively target specific protein kinases. Additional contributions from his lab include the creation of fluorescent probes of these enzyme. In addition to protein kinases, Lawrence, in collaboration with Professor Zhong-Yin Zhang, explored the substrate specificity of protein tyrosine phosphatases, studies which led to the acquisition of the first potent and selective inhibitors of this enzyme family.

The University of North Carolina at Chapel Hill

Lawrence, in collaboration with Nancy Allbritton, developed a series of ultrasensitive chemical tools to measure biological activity in single human cells in order to guide cancer therapy in the form of predictive personalized pharmacology. In addition, Lawrence and his research team developed chemical and genetic methods for controlling protein activity using light. The chemical strategy has been used “to turn [signaling] pathways on and off noninvasively (which) could boost efforts to understand these processes”. The genetic approach is part of the field of optogenetics, which enables the light-activated protein to be genetically encoded. Expression of the protein and targeted illumination provides precise spatial and temporal control of biological processes and is employed as a tool for studying cellular signaling.

Lawrence's lab also developed a strategy for delivering therapeutic agents to diseased sites using laser light. The tunable temporal and spatial control associated with the technology provides opportunities for cell-based therapies of a variety of diseases. The phototherapeutics technology offers a number of potential clinical advantages and serves as a therapeutic platform for Covalt Bio, a biotechnology company.

In the field of education, Lawrence created the Introduction to Laboratory Safety course built around case studies in response to the spate of deaths and serious injuries in academic research laboratories. The course was subsequently transformed into an online American Chemical Society training exercise in collaboration with Olivia Williams, David Finster, and Michael Blayney. In addition, he developed immersive virtual reality research laboratory environments used for training purposes.

References

This article "David Scott Lawrence" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:David Scott Lawrence. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

---